“Functional and Anatomical Outcomes Following Intravitreal Bevacizumab in Treatment-Naïve Centre-Involving Diabetic Macular Edema: A 3-Month Prospective Evaluation”, J. Heal. Rehab. Sci., vol. 4, no. 2, pp. 1–10, Dec. 2025, doi: 10.33700/jhrs.4.2.172.